Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The STAT1–importin KPNA1 nuclear import pathway is a fundamental signaling axis responsible for the nuclear translocation of Signal Transducer and Activator of Transcription 1 (STAT1) following cytokine stimulation. Upon phosphorylation by Janus kinases (JAKs) in response to interferons (IFNs), STAT1 forms dimers that expose a nuclear localization signal (NLS) specifically recognized by Karyopherin subunit alpha 1 (KPNA1, also known as Importin alpha 5). KPNA1 acts as an adapter to link STAT1 to the Importin beta 1 transport machinery for passage through the nuclear pore complex (Fagerlund et al., 2002, PMID: 11854287). Once inside the nucleus, STAT1 binds to specific DNA sequences to initiate the transcription of genes involved in antiviral defense, cell growth inhibition, and immune regulation (UniProt P42224). This pathway is a critical target for viral subversion; for example, the Ebola virus VP24 protein competitively binds to the C-terminal region of KPNA1 to block STAT1 entry, thereby suppressing the host's innate immune response (Zhang et al., 2012, PMID: 22532601). Pharmacological modulation of this pathway, such as through the use of broad importin inhibitors like Ivermectin or experimental peptides, offers a strategy for treating viral infections and potentially hyper-inflammatory conditions (Wagstaff et al., 2012, PMID: 22417684). However, therapeutic targeting must be carefully managed due to the risk of systemic immunosuppression and the potential disruption of other essential nuclear transport processes mediated by the karyopherin family.
Inhibition of the protein-protein interaction between phosphorylated STAT1 dimers and the Karyopherin subunit alpha 1 (KPNA1) adapter, preventing the nuclear translocation of STAT1 and the subsequent activation of interferon-stimulated genes.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal transducer and activator of transcription 1 (STAT1)–Karyopherin subunit alpha 1 (KPNA1) nuclear import pathway (STAT1–KPNA1 pathway).